Labcorp Holdings (LTS:0JSY) 3-Month Share Buyback Ratio: -0.12% (As of Mar. 2026 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0JSY Labcorp Holdings Inc LTS:0JSY
78 GF Score
Price $279.99
GF Value $270.30
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Labcorp Holdings 3-Month Share Buyback Ratio?

Labcorp Holdings LTS:0JSY +0.05% 78 3-Month Share Buyback Ratio is -0.12 as of Mar. 2026. GuruFocus rates LTS:0JSY with a GF Score™ of 78/100 and a GF Value™ of $270.30 (Fairly Valued). The stock has 6 warning signs investors should review.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Labcorp Holdings's current 3-Month Share Buyback Ratio was -0.12%.


Labcorp Holdings  (LTS:0JSY) 3-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.


Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.


Labcorp Holdings 3-Month Share Buyback Ratio Related Terms


LTS:0JSY vs DGX, GH, MTD: 3-Month Share Buyback Ratio Comparison

For the Diagnostics & Research subindustry, Labcorp Holdings's 3-Month Share Buyback Ratio, along with its competitors' market caps and 3-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labcorp Holdings 3-Month Share Buyback Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's 3-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Labcorp Holdings's 3-Month Share Buyback Ratio falls into.


LTS:0JSY
78GF Score
Labcorp Holdings Inc LTS:0JSY
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Labcorp Holdings 3-Month Share Buyback Ratio Calculation

Labcorp Holdings's 3-Month Share Buyback Ratio for the quarter that ended in Mar. 2026 is calculated as

3-Month Share Buyback Ratio=(Shares Outstanding (EOP) (Dec. 2025 ) - Shares Outstanding (EOP) (Mar. 2026 )) / Shares Outstanding (EOP) (Dec. 2025 )
=(82.200 - 82.300) / 82.200
=-0.12%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a 3-Month Share Buyback Ratio of -0.12 mean?
Labcorp Holdings (LTS:0JSY) has a 3-Month Share Buyback Ratio of -0.12 as of Mar. 2026. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Labcorp Holdings and its competitors.
Is Labcorp Holdings' 3-Month Share Buyback Ratio too high?
Labcorp Holdings' current 3-Month Share Buyback Ratio is -0.12. Overall, Labcorp Holdings has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Labcorp Holdings' 3-Month Share Buyback Ratio compare to DGX and GH?
Labcorp Holdings' 3-Month Share Buyback Ratio of -0.12 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Medical Diagnostics & Research company?
A good 3-Month Share Buyback Ratio depends on the Medical Diagnostics & Research industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Labcorp Holdings and its competitors. Labcorp Holdings's current 3-Month Share Buyback Ratio is -0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labcorp Holdings stock overvalued right now?
Based on GuruFocus' analysis, Labcorp Holdings (LTS:0JSY) is currently considered Fairly Valued. The stock's GF Value™ is $270.30, compared to a current price of $279.99 — trading 3.6% above its estimated fair value. The current 3-Month Share Buyback Ratio is -0.12. Labcorp Holdings' overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For Labcorp Holdings (LTS:0JSY), the current 3-Month Share Buyback Ratio is -0.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Labcorp Holdings (LTS:0JSY) Overvalued in 2026?

Based on GuruFocus' analysis, Labcorp Holdings stock appears to be overvalued. The current stock price of $279.99 is trading 3.6% above its estimated GF Value™ of $270.30. GuruFocus considers Labcorp Holdings to be Fairly Valued.

Key valuation signals for LTS:0JSY:

  • 3-Month Share Buyback Ratio: -0.12
  • GF Value™: $270.30 vs. price of $279.99 (3.6% above fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the LTS:0JSY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Labcorp Holdings Business Description

Other Exchanges LH:USAN6B:Germany
Address 358 South Main Street, Burlington, NC, USA, 27215
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
78GF Score

Get the complete analysis for LTS:0JSY

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$279.99
Price
$270.30
GF Value